DANVERS, MASS. – Beckman Coulter Genomics today announced a completely automated, high-capacity, target capture sequencing service that delivers quality sequencing data and streamlines sample preparation for targeted next generation sequencing.

Utilizing Agilent SureSelect Target Enrichment technology with the Beckman Coulter SPRIworks Fragment Library System for automated library construction and the Biomek Laboratory Automation Workstation for liquid handling provides high quality, reproducible samples ready for sequencing. Sequencing is performed on the Illumina GAII and HiSeq 2000 platforms.

“By automating this pipeline and maximizing our target capture sequencing capacity, we’re able to offer our customers a high-throughput solution, with faster project turnaround times and reproducible sequencing data,” said William Donahue, PhD, manager of molecular biology for Beckman Coulter Genomics. “Our LIMS sample tracking also enables large numbers of samples to be processed at the same time, significantly reducing the risk of sample mix-up that exists in a manual process.”

The solution is well suited to projects with a focus on key genomic regions of interest and provides scalable, cost-efficient sequencing of relevant samples in both small and large quantities. For more information, please visit: https://www.beckmangenomics.com/genomic_services/dna_sequencing/automated_target_capture.html.

About Beckman Coulter Genomics

Beckman Coulter Genomics, headquartered in Danvers, Mass., is a leading provider of genomic services and nucleic acid purification products, serving life science researchers and the pharmaceutical industry throughout the world. The company, a wholly owned subsidiary of Beckman Coulter, was created by combining Cogenics with Beckman Coulter’s Agencourt Bioscience. By providing technical expertise, combined with personalized service, Beckman Coulter Genomics delivers the highest quality data, robust analyses and innovative thinking. For more information, visit www.beckmangenomics.com.

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, Calif., develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 275,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represents about 80 percent of the company’s 2010 revenue of $3.7 billion. For more information, visit www.beckmancoulter.com.

SureSelect is a registered trademark of Agilent Technologies, Inc.

HiSeq is a registered trademark of Illumina, Inc.

SPRIworks, Biomek, Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc.